The United States Pneumonia Vaccines Market Size is to be Worth Over USD 9 Billion by 2026
The United States Pneumonia Vaccine Market Size, Market Analysis, Revenue Opportunity, Competitive Analysis and Forecast 2020 - 2026 provides a comprehensive analysis of the fast-evolving, high-growth United States pneumonia vaccines market. The report offers the most up-to-date industry data on the actual market situation and future outlook for the United States pneumonia vaccines market. The report provides historical market data for 2015 - 2019, and forecasts from 2020 till 2026.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2026. The report provides a clear insight into current and future developments of the United States pneumonia vaccines market. The report explores a detailed analysis of the top 5 vaccines market assessment in the United States from 2015 to 2019 and forecasts to 2026. The report also details the latest information about the pneumonia vaccines' pricing trends and analysis. Moreover, the report offers insight into the clinical trials and the latest happenings in the pneumonia vaccines market. It also covers reimbursement patterns and offers a clear view of the regulatory landscape.
Additionally, the report includes an assessment of promising vaccines in clinical development by major companies. Key trends in terms of collaboration deals, licensing agreement and partnership deals are analysed with details. The report also examines the main market growth driving and restraining forces and also gives an all-round future outlook through 2026.
The report also provides comprehensive profiles of the dominant players in the country’s pneumonia vaccines market such as Pfizer and Merck with important details on companies’ vaccines portfolio and the latest developments. Other emerging players such as GlaxoSmithKline (GSK), LG Chem, and SK Chemical (Sanofi Pasteur) are making novel technology-based pneumonia vaccines that are likely to affect the market share during the forecast period.
The Major Companies Dominating this Market for its Products, Services, and Continuous Product Developments are:
- Merck
- Pfizer
- GlaxoSmithKline (GSK)
- LG Chem
- SK Chemical (Sanofi Pasteur)
The Following 5 Leading Pneumonia Vaccines Are Detailed with Market Size and Six-Years Forecast
- Prevnar / Prevnar 13
- Pneumovax 23
- V114
- PF-06482077
- GSK3
Key Topics Covered in the Report:
- The Market Size of the United States Pneumonia Vaccines Market with Six Years Forecast
- The Market Size of the 5 Leading Pneumonia Vaccines with Six Years Forecast
- Provides Comprehensive Insights on the Latest Pneumonia Vaccines Pricing Trends and Analysis
- Detailed Insights of the Regulatory Framework of the US Pneumonia Vaccines Market
- Features Reimbursement Patterns of the US Pneumonia Vaccines Market
- An Insightful Analysis of the Promising Pneumonia Vaccines in the Clinical Development
- Reviews Most Recent Clinical Trials of the Pneumonia Vaccines
- Delivers a Latest Happenings in the Pneumonia Vaccines Market
- Provides Key Trends with Respect to Collaboration Deals, Partnerships Deals and Licensing Agreement
- Investigates the Key Growth Drivers and Restraints of the US Pneumonia Vaccines Market
- A Comprehensive List of the Key Market Players Along with the Analysis of their Current Vaccines Portfolios, and Recent Development
The Report Helps Answer the Following Questions:
- What is the current size of the overall united states pneumonia vaccines market? How much will this market be worth from 2020 to 2026?
- What are the leading vaccines? What are their revenue potentials to 2026?
- Which vaccine provides the highest market share?
- What are the main drivers and restraints in the united states pneumonia vaccines market?
- What are the major deals happenings in the pneumonia vaccines market?
- What are the united states pneumonia vaccines' pricing trends and analysis?
- What are the various pneumonia vaccines available in the United States?
- Who are the leading companies and what are their activities, promising vaccines in clinical development, recent developments, and prospects?
Table of Contents
1. Executive Summary
2. United States Pneumonia Vaccines Market Size & Analysis (2015 - 2026)
3. United States Pneumonia Vaccines Market Assessment & Opportunity (Value), 2015 - 2026
3.1 Prevnar / Prevnar 13
3.2 Pneumovax 23
3.3 V114
3.4 PF-06482077
3.5 GSK3
4. Key Drivers and Inhibitors of the United States Pneumonia Vaccines Market
4.1 Market Drivers
4.2 Market Inhibitors
5. United States Pneumonia Vaccines Pricing Trends & Analysis
6. United States Pneumonia Vaccines Reimbursement Policies
7. United States Pneumonia Vaccines Regulatory System
8. Promising Pneumonia Vaccines in the Clinical Development
9. Pneumonia Vaccines Clinical Trials Insight by Phase, Company & Country
10. Latest Happenings in the Pneumonia Vaccines Market
11. Major Deals in the Pneumonia Vaccines Market
11.1 Collaboration Deals
11.2 Licensing Agreement
11.3 Partnership Deals
12. Key Companies Analysis
12.1 Merck
12.1.1 Business Overview
12.1.2 Vaccines Portfolio
12.1.3 Recent Development
12.2 Pfizer
12.2.1 Business Overview
12.2.2 Vaccines Portfolio
12.2.3 Recent Development
List of Tables:
Table 5-1: United States Pneumonia Adult Vaccines Price, 2019 - 2020
Table 5-2: United States Pneumonia Pediatric Vaccines Price, 2019 - 2020
Table 7-1: United States Simplified Regulatory Pathway from Preclinical to the Marketing Authorization
Table 10-1: Collaboration Deals in the Pneumonia Vaccines Market
Table 10-2: Licensing Agreement in the Pneumonia Vaccines Market
Table 10-3: Partnership Deals in the Pneumonia Vaccines Market
List of Figures:
Figure 2-1: United States Pneumonia Vaccines Market Size (Million US$),2015 - 2019
Figure 2-2: United States Pneumonia Vaccines Market Size Forecast (Million US$),2020 - 2026
Figure 3-1: United States Prevnar/Prevnar 13 Market Value (Million US$),2015 - 2019
Figure 3-2: United States Prevnar/Prevnar 13 Market Value Forecast (Million US$),2020 - 2026
Figure 3-3: United States Pneumovax 23 Market Value (Million US$),2015 - 2019
Figure 3-4: United States Pneumovax 23 Market Value Forecast (Million US$),2020 - 2026
Figure 3-5: United States V114 Market Value (Million US$),2022 - 2026
Figure 3-6: United States PF-06482077 Market Value (Million US$),2022 - 2026
Figure 3-7: United States GSK3 Market Value (Million US$),2024 - 2026
Companies Mentioned
- GlaxoSmithKline (GSK)
- LG Chem
- Merck
- Pfizer
- SK Chemical (Sanofi Pasteur)
